日本新薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4516/E00931 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2015/03/06 | 日証協 | 419,986株 | +1.28% | 258,000株 | +6.49% | 516,913株 | +6.75% | 118,653株 | +196.63% |
2015/02/27 | 日証協 | 414,673株 | -24.57% | 242,268株 | +7.98% | 484,247株 | -17.04% | 40,000株 | -20% |
2015/02/20 | 日証協 | 549,711株 | -19.83% | 224,372株 | +280.29% | 583,711株 | -4.17% | 50,000株 | +59.36% |
2015/02/13 | 日証協 | 685,711株 | -2.2% | 59,000株 | -76.48% | 609,087株 | -13.07% | 31,376株 | -71.34% |
2015/02/06 | 日証協 | 701,150株 | -0.02% | 250,884株 | -16.51% | 700,625株 | +1.45% | 109,458株 | +132.89% |
2015/01/30 | 日証協 | 701,308株 | +1.11% | 300,504株 | +637.2% | 690,625株 | -0.84% | 47,000株 | -45.02% |
2015/01/23 | 日証協 | 693,606株 | -2.38% | 40,763株 | -83.69% | 696,503株 | +3.16% | 85,478株 | +0.43% |
2015/01/16 | 日証協 | 710,514株 | -2.66% | 249,903株 | +2% | 675,140株 | +1.07% | 85,115株 | +156.02% |
2015/01/09 | 日証協 | 729,934株 | +1.56% | 245,000株 | +338.66% | 667,986株 | +4.5% | 33,245株 | -36.07% |
2014/12/30 | 日証協 | 718,748株 | +4.46% | 55,852株 | +8.67% | 639,231株 | +5.22% | 52,000株 | -6.72% |
2014/12/26 | 日証協 | 688,081株 | +4.36% | 51,398株 | -76% | 607,532株 | +2.36% | 55,745株 | +16.69% |
2014/12/19 | 日証協 | 659,357株 | -4.64% | 214,189株 | -14.71% | 593,534株 | +1.22% | 47,772株 | -68.15% |
2014/12/12 | 日証協 | 691,476株 | -3.88% | 251,119株 | +23.73% | 586,359株 | -16.29% | 150,000株 | +29.4% |
2014/12/05 | 日証協 | 719,419株 | -8.75% | 202,965株 | -55.64% | 700,459株 | -4.11% | 115,924株 | -19.5% |
2014/11/28 | 日証協 | 788,380株 | +12.47% | 457,580株 | +88.2% | 730,497株 | +10.16% | 144,000株 | +139.84% |
2014/11/21 | 日証協 | 700,988株 | -8.66% | 243,140株 | -47.88% | 663,105株 | -13.97% | 60,039株 | -32.54% |
2014/11/14 | 日証協 | 767,445株 | -1.35% | 466,523株 | +115.01% | 770,760株 | -1.85% | 89,000株 | -61.29% |
2014/11/07 | 日証協 | 777,931株 | +11.94% | 216,980株 | -23.85% | 785,300株 | +17.69% | 229,900株 | +248.09% |
2014/10/31 | 日証協 | 694,954株 | +4.92% | 284,936株 | -31.6% | 667,277株 | +5.27% | 66,046株 | -41.08% |
※株式分割は考慮していませんのでご注意ください。
Page Top